These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33370632)

  • 1. Crosstalk between oncolytic viruses and autophagy in cancer therapy.
    Jin KT; Tao XH; Fan YB; Wang SB
    Biomed Pharmacother; 2021 Feb; 134():110932. PubMed ID: 33370632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
    Tazawa H; Kuroda S; Hasei J; Kagawa S; Fujiwara T
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
    Tazawa H; Kagawa S; Fujiwara T
    Acta Med Okayama; 2013; 67(6):333-42. PubMed ID: 24356717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.
    Liikanen I; Ahtiainen L; Hirvinen ML; Bramante S; Cerullo V; Nokisalmi P; Hemminki O; Diaconu I; Pesonen S; Koski A; Kangasniemi L; Pesonen SK; Oksanen M; Laasonen L; Partanen K; Joensuu T; Zhao F; Kanerva A; Hemminki A
    Mol Ther; 2013 Jun; 21(6):1212-23. PubMed ID: 23546299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer.
    Zahedi-Amiri A; Malone K; Beug ST; Alain T; Yeganeh B
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.
    Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG
    World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.
    Tan DQ; Zhang L; Ohba K; Ye M; Ichiyama K; Yamamoto N
    Eur J Immunol; 2016 Apr; 46(4):919-28. PubMed ID: 26763072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
    Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
    Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning killer into cure -- the story of oncolytic herpes simplex viruses.
    Zhang SX
    Discov Med; 2015 Nov; 20(111):303-9. PubMed ID: 26645902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
    Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
    Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response.
    Wu YY; Sun TK; Chen MS; Munir M; Liu HJ
    Front Cell Infect Microbiol; 2023; 13():1142172. PubMed ID: 37009515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusogenic oncolytic herpes simplex viruses as a potent and personalized cancer vaccine.
    Li QX; Liu G; Zhang X
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1773-85. PubMed ID: 21740353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting autophagy to enhance oncolytic virus-based cancer therapy.
    Meng S; Xu J; Wu Y; Ding C
    Expert Opin Biol Ther; 2013 Jun; 13(6):863-73. PubMed ID: 23488666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viruses as nanomedicine for cancer.
    Badrinath N; Heo J; Yoo SY
    Int J Nanomedicine; 2016; 11():4835-4847. PubMed ID: 27703350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling.
    Xia M; Gonzalez P; Li C; Meng G; Jiang A; Wang H; Gao Q; Debatin KM; Beltinger C; Wei J
    J Virol; 2014 May; 88(9):5152-64. PubMed ID: 24574393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy.
    Keshavarz M; Solaymani-Mohammadi F; Miri SM; Ghaemi A
    J Biomed Sci; 2019 Jun; 26(1):48. PubMed ID: 31217023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.